|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 281 SEK | +0.07% |
|
+7.66% | +5.24% |
Swedish Orphan Biovitrum AB (publ) reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 6,844 million compared to SEK 5,991 million a year ago. Net income was SEK 1,026 million compared to SEK 1,386 million a year ago.
Basic earnings per share from continuing operations was SEK 3.02. Diluted earnings per share from continuing operations was SEK 2.99.
| 1st Jan change | Capi. | |
|---|---|---|
| +5.24% | 8.71B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.35B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| -43.00% | 11.51B | |
| -8.42% | 8.12B |
SWEDISH ORPHAN BIOVITRUM AB 
